Healthcare has become the largest single market for Securitag Assembly Group, the Taiwanese RFID tag and label manufacturer listed in Taipei as TPEx 6417 and known across the industry as SAG. Medical and pharmaceutical customers accounted for 33% of revenue in the first nine months of 2026, up from 30% across 2025, moving ahead of the access control business the company has traded on for years.
SAG set out the figures at its investor conference on 12 November 2026, hosted by KGI Securities at the broker’s Taipei headquarters. General manager Chiang Hung-yu presented. The company is headquartered in Taichung, employs about 460 people, has paid-in capital of NT$422.74m and sells through its SAG Japan and SAG USA subsidiaries. Its business is RFID transponders and RFID solutions, with an Ambient IoT line added more recently.
The 2027 claim came from the floor, not the slides
Chiang told the conference he expects double-digit business growth again in 2027, in remarks reported by the Taiwanese financial outlet cnyes. That figure is worth handling carefully. The 24-page deck SAG published alongside the event contains no 2027 guidance at all, no Japan plant and no capital expenditure figure, and it carries a standard forward-looking disclaimer. The growth number is management commentary from the conference floor rather than a published forecast.
Chiang was also describing total business growth rather than RFID revenue specifically. In SAG’s case the distinction is close to academic: RFID tags and labels together made up about 99% of revenue in the first nine months of 2026, with everything else accounting for the remaining 1%.
A fourth record quarter in a row
Third-quarter revenue reached NT$509.85m, up 25.85% on the same quarter of 2025 and up 0.69% on the second quarter of 2026. SAG described it as the fourth consecutive quarter of record revenue. Nine-month revenue of NT$1.444bn, up 22.08% year on year, is an all-time high for the company.
| Measure | Q3 2026 | First nine months of 2026 |
|---|---|---|
| Revenue | NT$509.85m, up 25.85% | NT$1.444bn, up 22.08% |
| Gross margin | 34.38% | 34.55%, up 3.59 points |
| Operating margin | 20.19% | 20.12%, up 4.14 points |
| Net profit | NT$87.49m, up 54.64% | NT$240.32m, up 74.92% |
| Earnings per share | NT$2.07 | NT$5.68, up 74.77% |
Third-quarter net profit of NT$87.49m was a single-quarter high, on a net margin of 17.16%. Gross margin held above 34% for a third straight quarter. Return on equity for the nine months was 17.89%, up 6.67 points on the same period of 2025. SAG attributed the profit growth to higher revenue, better gross margin and foreign exchange gains.
Where the growth is coming from
By sector, healthcare took 33% of nine-month revenue, access control 26%, track and trace 14%, security 6% and other applications 21%. SAG calls healthcare its target market and says medical customers are continuing to convert products from older identification methods to RFID. It describes access control as a mature market, where growth in 2026 came from one customer upgrading the security of its own products rather than from new demand.
By product, the RFID Tag line of cards, hard tags and key fobs took 68% of nine-month revenue, and the RFID Label line of inlays and labels 31%. Label growth came mainly from medical consumables. Hard tag sales rose on steady industrial demand, consumer project volume and customers finishing a period of inventory destocking.
SAG remains an export business, with 97% of revenue earned outside Taiwan. The Americas took 42% of nine-month revenue, Asia 27%, Europe 22%, Oceania 6% and Taiwan itself 3%. The company notes that its Asian sales are largely to the Asian contract manufacturers of European and American customers, so the regional split reflects where goods are made rather than where they are finally sold.
A Japanese line aimed at pharmaceutical customers
Also reported from the conference, and likewise absent from the deck, is a plan for a production line at Yonezawa in Yamagata Prefecture, Japan, in a factory rented from Siward Crystal Technology. Siward is a Taiwanese maker of crystal frequency components and SAG’s largest institutional shareholder, holding 13.63%, and Siward’s chairman Tseng Ying-tang is also chairman of SAG. Production is reported to start in the second quarter of 2028, with capital expenditure rising to NT$160m.
The logic is supply chain geography. Japanese pharmaceutical and medical device customers increasingly want tags produced outside Taiwan and China, and a line inside Japan answers that directly. It is a notable commitment for a company of SAG’s size, and it is the clearest signal yet of where management thinks the next phase of growth sits.
DSCSA and the Digital Product Passport as demand drivers
SAG’s healthcare case rests partly on the US Drug Supply Chain Security Act, the law that requires an interoperable, package-level electronic record of prescription drug movements through the US supply chain. SAG is promoting RFID source tagging, meaning the tag is applied during manufacture rather than later in the chain, to link a physical pack to its digital record, and says it is working with industry partners on GS1 standards and applying source tagging to liquid drugs.
The company puts the headroom bluntly. It estimates healthcare RFID is only 5% to 10% developed, delivering roughly US$1bn to US$3bn of value a year today against a potential US$13bn to US$38bn. By comparison it puts retail, the most mature application, at 35% to 50% developed with US$7bn to US$12bn realised annually. Those are SAG’s own estimates, presented to investors, and should be read as such.
On the European side, SAG is selling washable embedded dual-frequency labels that combine NFC and UHF on one tag, aimed at the EU Digital Product Passport, the ESPR-based regime that will require a machine-readable record of a product’s materials, repair and recycling information. SAG’s deck notes that the European Commission launched the DPP registry in July 2026 and that the delegated act covering textiles is expected in the fourth quarter of 2027. The company says a luxury brand has already adopted the labels, with the results written up in a 2026 white paper, but does not name the brand.
Ambient IoT and battery-free Bluetooth
SAG’s third strand is Ambient IoT, the term for connected devices that harvest the energy they need from radio waves, light or motion rather than carrying a battery. The company moved from battery-powered Bluetooth Low Energy tags in 2025 to battery-free BLE tags in 2026, aimed at apparel, and is building roll-to-roll capacity to make them in volume.
Citing Bluetooth SIG and ABI Research figures published in August 2026, SAG expects global Bluetooth smart tag shipments to rise from 169 million in 2026 to 1.9 billion in 2031, a compound annual growth rate of 62% covering both battery-powered and energy-harvesting tags. Whether that materialises is another question, but it explains why a company whose passive UHF tag business is growing at better than 20% a year is spending engineering effort on a different radio altogether.
More company results and funding coverage is collected on the Company and Financial hub, and SAG’s medical work alongside other deployments on the Healthcare hub.
Read more at https://www.sag.com.tw/corporate-information-session/
